From Lab To Life
CCRM is a catalyst for commercializing regenerative medicine-based technologies and cell and gene therapies. We enable product development through the unique translational platforms that address the key bottlenecks in regenerative medicine commercialization.
A New Approach
CCRM provides innovative CDMO services to enable the development and commercialization of cell and gene therapies and regenerative medicine technologies. With our customer-focused approach customized to each client, we provide process development and GMP-compliant manufacturing services tailored to our clients’ timelines, financing, ambitions and needs.
From a hub with valuable technical information and resources to support the manufacturing of cell and gene therapies, to a blog that reveals an insider’s perspective on stem cells and regenerative medicine, to journal articles and white papers, our educational resources share everything you need to know.